Triglyceride to high-density lipoprotein cholesterol ratio as a predictor of long-term mortality in patients with coronary artery disease after undergoing percutaneous coronary intervention: a retrospective cohort study

Table 3 Incidence of outcomes on multivariate Cox proportional hazards regression models and log-rank test

Outcomes	HR (95% CI)	P-Value	Adjusted HR (95% CI)^a	P-Value	log-rank test
Outcomes	HR (95% CI)	P-Value	Adjusted HR (95% CI)^a	P-Value	χ²	P-Value
ACM	1.521 (1.007–2.299)	0.046	2.042 (1.264–3.300)	0.004	4.039	0.044
CM	1.264 (0.762–2.094)	0.364	1.707 (0.952–3.061)	0.072	0.830	0.362
MACEs	1.073 (0.857–1.344)	0.540	1.143 (0.898–1.456)	0.277	0.378	0.539
Heart failure	1.912 (1.519–2.406)	< 0.001	1.700 (1.347–2.147)	< 0.001	32.172	< 0.001
MACCEs	0.973 (0.801–1.182)	0.784	1.023 (0.832–1.260)	0.827	0.076	0.783

Abbreviation: THR Triglyceride to high-density lipoprotein cholesterol ratio, ACM All-cause mortality, CM Cardiac mortality, MACEs Major Adverse cardiovascular events including cardiac death, bleeding events, readmission, MACCEs Major adverse cardiovascular and cerebrovascular events including MACEs and stroke. Note: The boldfaced P-Values are statistically different
^aAdjusted for age, gender, family history, hypertension, diabetes, smoking, alcohol consumption, creatinine, uric acid, and total cholesterol

ISSN: 1476-511X